Homology Medicines Reports First Quarter 2020 Financial Results and Recent Highlights
- Progressed the pheNIX Trial for PKU and Added Clinical Sites, Completed Clinical Supply for Phase 1/2 and Began Manufacturing Pivotal Supply - - Executed Commercial Manufacturing Process at 2,000-Liter Bioreactor Scale - - Implemented Plans to Minimize …